| A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form (NCT04391868) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2021-01-30 |
| An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants (NCT04176367) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2019-12-17 |
| Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (NCT03768726) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2018-12-21 |
| Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets (NCT03711708) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2018-11-06 |
| Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure) (NCT03342690) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2017-07-05 |
| Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE) (NCT02958527) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2016-10-03 |
| PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With Pregabalin (NCT02868359) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2016-10-01 |
| Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting (NCT02565615) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2016-06-22 |
| Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers (NCT02725112) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2016-02-12 |
| Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects (NCT02651623) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2016-01-01 |
| A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects (NCT02637193) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2015-12-01 |
| Effects of Oral Sildenafil on Mortality in Adults With PAH (NCT02060487) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2014-09-22 |
| A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. (NCT02072824) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2014-09-16 |
| PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin (NCT02273908) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2014-07-01 |
| Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder (NCT02075047) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2014-05-23 |
| Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component (NCT01838044) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-10-01 |
| Actual Use Trial of Atorvastatin Calcium 10 mg (NCT01964326) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-10-01 |
| A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn (NCT01720524) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-08-05 |
| Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers (NCT01888497) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-07-29 |
| Patient Reported Outcomes in Pulmonary Arterial Hypertension (NCT01792622) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-07-01 |
| A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. (NCT01747915) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-04-03 |
| Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan) (NCT01773993) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-02-01 |
| A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women (NCT01727791) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-12-01 |
| A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN) (NCT01801982) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-11-01 |
| Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain (NCT01701362) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-10-01 |
| Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation (NCT00877955) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-09-01 |
| Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects (NCT01699724) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-09-01 |
| Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension (NCT01642407) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-08-24 |
| Food Effect Study For New Formulation (NCT01656798) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-08-01 |
| Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil (NCT01737203) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-08-01 |
| A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients (NCT01607593) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-08-01 |
| Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES) (NCT01302080) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-04-04 |
| A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted (NCT01443169) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-03-01 |
| IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn (NCT01360671) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-03-01 |
| A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures (NCT01463306) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-02-21 |
| A Study For Pregabalin In Patients With Fibromyalgia (NCT01387607) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-02-06 |
| Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study (NCT01298466) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-02-01 |
| NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark (NCT01524796) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-01-01 |
| Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD) (NCT01485887) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-01-01 |
| Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain (NCT01455415) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-12-01 |
| Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN) (NCT01455428) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-12-01 |
| Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan) (NCT01441401) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-12-01 |
| Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD) (NCT01441440) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-11-01 |
| A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression (NCT01432236) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-10-01 |
| Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) (NCT01474772) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-10-01 |
| Pharmacokinetics and Relative Bioavailability Study (NCT01521767) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-10-01 |
| A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years (NCT01389596) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-09-27 |
| Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan) (NCT01279850) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-08-01 |
| Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy (NCT01332149) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-07-01 |
| Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension (NCT01365585) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-07-01 |
| Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition (NCT01389609) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-07-01 |
| Africa and Middle East Cardiovascular Epidemiological Study (NCT01243138) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-07-01 |
| An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet (NCT01342198) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-06-01 |
| An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites (NCT01330472) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-05-01 |
| A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia (NCT01355068) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-05-01 |
| A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets (NCT01322867) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-05-01 |
| Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation (NCT01027689) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-04-01 |
| Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation (NCT01285505) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-04-01 |
| Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01321671) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-04-01 |
| Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder (NCT01302938) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-03-01 |
| Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients (NCT01271933) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-03-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers (NCT01270815) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-03-01 |
| Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia (NCT01270828) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-03-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers (NCT01257529) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-03-01 |
| Once-A-Day Pregabalin For Partial Seizures (NCT01262677) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-02-17 |
| Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan) (NCT01256593) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-02-05 |
| Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01291524) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-02-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01257516) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-02-01 |
| Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study (NCT01280747) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-01-01 |
| A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions (NCT01247805) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-01-01 |
| Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet (NCT01256151) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-01-01 |
| Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) (NCT01069861) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| Long-Term Non-Interventional Latanoprost Study (NCT01265719) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| Amlodipine 10mg Drug Use Investigation (NCT01252563) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food. (NCT01254396) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet. (NCT01254383) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01220219) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-11-01 |
| A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Conditions (NCT01235195) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-11-01 |
| Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension (NCT01191008) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-10-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule (NCT01202422) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-10-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule (NCT01202435) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-10-01 |
| An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain (NCT01202227) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-09-01 |
| Pregabalin In Adolescent Patients With Fibromyalgia (NCT01020526) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-09-01 |
| Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction (NCT01176968) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-09-01 |
| Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients (NCT01190007) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-08-01 |
| A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions (NCT01046162) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-15 |
| One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome (NCT01113541) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Eletriptan Pharmacokinetics In Korean Males (NCT01139515) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Bioequivalence Study Of Phenytoin Suspension Versus Epamin® In 34 Healthy Volunteers. (NCT01122940) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Pregabalin Trial In HIV Neuropathic Pain (NCT01145417) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (NCT01124877) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure (NCT01115855) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil (NCT01108900) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196) (NCT01117220) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-06-01 |
| Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) (NCT01107743) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-06-01 |
| Adolescent Fibromyalgia Study (NCT01020474) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-05-01 |
| Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets (NCT01138826) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-05-01 |
| Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor (NCT01150903) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-05-01 |
| 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects (NCT01061372) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-05-01 |
| Bioequivalence Study Of PHENYTOIN Suspension Made By Pfizer, Versus EPAMIN® Made By McNeil LA LLC In Healthy Volunteers Under Fasting Conditions (NCT01122953) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-04-01 |